Marie Perier‐Muzet

Author

Marie Perier‐Muzet

Université Claude Bernard Lyon 1

Also Known As

M. Perier-Muzet, M. Perier‐Muzet, M. Périer-Muzet, Marie Perier-Muzet, Marie Perier‐Muzet

Publications

607

Citations

H-Index

Concepts

All Affiliations

Université Claude Bernard Lyon 1 Centre de Recherche en Cancérologie de Lyon Hospices Civils de Lyon Inserm Centre National de la Recherche Scientifique

About

Marie Perier‐Muzet is an author at Université Claude Bernard Lyon 1 specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	267
2	Immunology	2	2	149
3	Geriatrics	1	1	80
4	Nephrology	1	1	20
5	Pathology	1	1	69

Marie Perier‐Muzet

Publications

525

Citations

H-Index

Page 1

	Year	Citations
<scp>ZEB</scp> 1‐mediated melanoma cell plasticity enhances resistance to <scp>MAPK</scp> inhibitors Geoffrey Richard, Stéphane Dalle, Marie‐Ambre Monet, EMBO Molecular Medicine	2016	124
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting Pauline Corbaux, Denis Maillet, Amélie Boespflug, European Journal of Cancer Similar OutcomesGeriatric OncologyOncologyAgingDisease Progression	2019	80
Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors Denis Maillet, Pauline Corbaux, Jean‐Jacques Stelmes, European Journal of Cancer Autoimmune DiseaseMedicineImmune Checkpoint InhibitorsImmunologyPathology	2020	69
Association of Immunotherapy With Overall Survival in Elderly Patients With Melanoma Marie Perier‐Muzet, Elodie Gatt, Julien Péron, JAMA Dermatology	2017	66
Melanoma Patients under Vemurafenib: Prospective Follow-Up of Melanocytic Lesions by Digital Dermoscopy Marie Perier‐Muzet, L. Thomas, Nicolas Poulalhon, Journal of Investigative Dermatology Dermoscopic ImageProspective Follow-upSurgical PathologyMelanomaMelanoma Patients	2013	63
New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma Cécile Teuma, Marie Perier‐Muzet, M. Nouvier, Cancer Chemotherapy and Pharmacology UrologyB-raf InhibitorMedicineMelanomaPharmacology	2016	35
Diagnostic Concordance in Tertiary (Dermatologists-to-Experts) Teledermoscopy: A Final Diagnosis-Based Study on 290 Cases A. Marchetti, Stéphane Dalle, Delphine Maucort‐Boulch, Dermatology Practical & Conceptual	2020	21
Adjunction of a MEK inhibitor to Vemurafenib in the treatment of metastatic melanoma results in a 60% reduction of acute kidney injury Cécile Teuma, Solenne Pelletier, Mona Amini-Adl, Cancer Chemotherapy and Pharmacology UrologyMetastatic Melanoma ResultsMedicineMelanomaImmune Checkpoint Inhibitor	2017	20
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study A. Bozonnat, M. Beylot‐Barry, O. Dereure, EClinicalMedicine	2024	17
Intraoperative dermoscopy features of subungual squamous cell carcinoma: a study of 53 cases V. Carlioz, Marie Perier‐Muzet, S. Debarbieux, Clinical and Experimental Dermatology	2020	15

Page 1